# RNA denaturation underlies circular RNA separation

**Authors:** Yanyi Jiang, Jørgen Kjems

PMC · DOI: 10.1093/nar/gkaf1160 · 2025-11-20

## TL;DR

This study explores how to better separate circular RNAs from linear RNA byproducts using techniques like gel electrophoresis and HPLC–SEC.

## Contribution

The study reveals that RNA denaturation is key for separation and shows how magnesium ions affect HPLC–SEC performance.

## Key findings

- RNA denaturation is essential for effective separation of circRNAs using gel electrophoresis and HPLC–SEC.
- Trace magnesium ions in RNA samples can significantly hinder circRNA separation via HPLC–SEC.
- Optimized denaturing conditions allow HPLC–SEC to purify circRNAs directly from crude reactions.

## Abstract

In vitro-synthesized circular RNAs (circRNAs) have emerged as a promising drug modality for RNA therapeutics due to their improved stability and reduced immunogenicity. However, effective analysis and purification of circRNAs pose critical challenges arising from the insufficient separation of circRNAs and linear RNA byproducts. In this study, we systematically evaluate the effectiveness of gel electrophoresis and high-performance liquid chromatography–size exclusion chromatography (HPLC–SEC) for separating circRNAs synthesized through ligase- or ribozyme-based strategies. While the synthesis strategy dictates the purification complexity, we demonstrate that both techniques rely on RNA denaturation to successfully separate circRNAs. Additionally, when using HPLC–SEC, we show that even a trace amount of magnesium ions in RNA samples can significantly compromise circRNA separation. Under optimized denaturing conditions, HPLC–SEC enables circRNA purification directly from crude enzymatic reactions, thereby streamlining the purification process. Our study provides mechanistic insights into circRNA separation, advancing the purity and scalability of circRNA-based therapeutics.

Graphical Abstract

## Linked entities

- **Chemicals:** magnesium ions (PubChem CID 888)

## Full-text entities

- **Genes:** STS (steroid sulfatase) [NCBI Gene 412] {aka ARSC, ARSC1, ASC, ES, SSDD, XLI}, RENBP (renin binding protein) [NCBI Gene 5973] {aka RBP, RNBP}
- **Diseases:** COVID-19 (MESH:D000086382), IVT (MESH:C566179)
- **Chemicals:** ice (MESH:D007053), copper (MESH:D003300), glycerol (MESH:D005990), pyrimidines (MESH:D011743), E (MESH:D004540), GMP (MESH:C066524), urea (MESH:D014508), EDTA (MESH:D004492), Phosphate (MESH:D010710), TE (MESH:D013691), nucleotides (MESH:D009711), KCl (MESH:D011189), water (MESH:D014867), NaCl (MESH:D012965), hydrogen (MESH:D006859), formamide (MESH:C031066), DTT (MESH:D004229), polyacrylamide (MESH:C016679), bisacrylamide (MESH:C021221), PB (MESH:D007854), tartrazine (MESH:D013645), Magnesium (MESH:D008274), salt (MESH:D012492), Agarose (MESH:D012685), bromophenol blue (MESH:D001978), HCl (MESH:D006851), SDS (MESH:D012967), guanosine (MESH:D006151), formaldehyde (MESH:D005557), GTP (MESH:D006160), xylene cyanol (MESH:C048951), TEMED (MESH:C005798), boric acid (MESH:C032688), MgCl2 (MESH:D015636), T4 (MESH:D013974), acrylamide (MESH:D020106), CL (MESH:D002713), TBE buffer (MESH:C069591), cytosine (MESH:D003596), AccuGel (-), APS (MESH:D000250)
- **Species:** Tequatrovirus T4 (species) [taxon 10665], Tetrahymena (genus) [taxon 5890], Coxsackievirus B3 (no rank) [taxon 12072]
- **Cell lines:** PIE — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_XM34), T4lig2 — Mus musculus (Mouse), Mouse lymphoma, Cancer cell line (CVCL_GZ29)

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12630139/full.md

---
Source: https://tomesphere.com/paper/PMC12630139